Genenta Science S.P.A. ADR (GNTA)

$1.81 +0.08 (4.62%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	40.81M
Revenue (ttm)	0.00
Net Income (ttm)	-7.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	162,000
Avg Vol	1,803,928
Day's Range	N/A - N/A
Shares Out	23.59M
Stochastic %K	44%
Beta	0.90
Analysts	Strong Buy
Price Target	$7.00

Company Profile

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules...

Industry: Biotechnology

Sector: Healthcare

Website: www.genenta.com

Address:

Via Olgettina No. 58, Milan, Italy

focafoca99 Jun. 24 at 1:25 PM

$GNTA outlines a severance agreement for CEO Pierluigi Paracchi and amends his non‑compete covenant.

1 · Reply

TheUnmaker Jun. 22 at 10:35 AM

$ADTX $PFSA $RGNX $GNTA $CNTX

0 · Reply

DylanGFM Jun. 22 at 8:54 AM

$GNTA todays just not your day is it buddy. see you later.

0 · Reply

DylanGFM Jun. 22 at 8:51 AM

$EHGO this is beautiful scalping PA I must say. Glad I chose the 4am route hahaha.. doesn't always pay off but it is hot right now and maybe $GNTA tries to break above the gap up its sitting with support on the 5 min. could get another huge stretched out field goal on the daily like with $GETY

0 · Reply